Atulkumar Gandhi, B.PHARM, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4870 W Clark Rd Ste 108, Ypsilanti, MI 48197 Phone: 734-528-9144 Fax: 734-528-9144 |
Nkemdilim Caroline Okoye, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2170 Washtenaw Rd, Ypsilanti, MI 48197 Phone: 734-485-3899 |
Dr. Lawrence Wesley Sautel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2170 Washtenaw Rd, Ypsilanti, MI 48197 Phone: 734-485-3899 |
Dr. Hussein Moussa Kaddouh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3749 Carpenter Rd, Ypsilanti, MI 48197 Phone: 734-975-4675 |
Mr. Alan Metz, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3100 Washtenaw Rd, Ypsilanti, MI 48197 Phone: 734-434-3566 Fax: 734-528-2715 |
Mrs. Gayle Marie Miller, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Ecorse Rd, Ypsilanti, MI 48198 Phone: 734-482-1034 Fax: 734-482-0091 |
Ebaa Saad Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3749 Carpenter Rd, Ypsilanti, MI 48197 Phone: 734-975-4675 |
Kassem Chehab, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1065 N Huron River Dr Ste 600, Ypsilanti, MI 48197 Phone: 734-547-5995 Fax: 734-547-5974 |
Michael Perkins Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2170 Washtenaw Rd, Ypsilanti, MI 48197 Phone: 734-485-3899 Fax: 734-485-7122 |
Darshna Patel, B.PHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4870 W Clark Rd Ste 108, Ypsilanti, MI 48197 Phone: 734-528-9144 Fax: 734-528-9146 |
Mrs. Jaini Anil, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 419 E Michigan Ave, Ypsilanti, MI 48198 Phone: 734-485-4621 |
Mrs. Ibironke O Akinbola, B.PHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2170 Washtenaw Rd, Ypsilanti, MI 48197 Phone: 734-485-3899 Fax: 734-485-7122 |
Candice Mitchell Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3825 Carpenter Rd, Ypsilanti, MI 48197 Phone: 734-973-1200 |
Wissam Ghozayel, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3145 W Clark Rd Ste 201, Ypsilanti, MI 48197 Phone: 734-470-0700 Fax: 734-470-0777 |
Trinh Nguyen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1771 E Michigan Ave, Ypsilanti, MI 48198 Phone: 734-482-9342 Fax: 734-483-8649 |
Arafat A Mohamed Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2170 Washtenaw Rd, Ypsilanti, MI 48197 Phone: 734-485-3899 |
Dr. Shajal Bufalini, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 5320 Elliott Dr # 202, Ypsilanti, MI 48197 Phone: 734-712-2227 Fax: 734-712-0229 |
Fadia Hashem, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2287 Ellsworth Rd Ste A, Ypsilanti, MI 48197 Phone: 734-434-2448 Fax: 734-434-2458 |
Mrs. Rachelle Lynn Roush, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5333 Mcauley Dr, Ypsilanti, MI 48197 Phone: 734-712-2222 Fax: 734-712-2189 |
George Joseph Sawaya Jr., PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3100 Washtenaw Rd, Ypsilanti, MI 48197 Phone: 734-434-3566 |
News Archive
BioLineRx Ltd., a biopharmaceutical development company, today reported its results for the third quarter ending September 30, 2011.
Diagnosed in toddlers, X-linked hypophosphatemia (XLH) is the most common form of heritable rickets, in which soft bones bend and deform, and tooth abscesses develop because infections penetrate soft teeth that are not properly calcified. Researchers at McGill University and the Federal University of Sao Paulo have identified that osteopontin, a major bone and tooth substrate protein, plays a role in XLH. Their discovery may pave the way to effectively treating this rare disease.
Johns Hopkins scientists have published laboratory data refuting studies that suggest blood vessels that form within brain cancers are largely made up of cancer cells. The theory of cancer-based blood vessels calls into question the use and value of anticancer drugs that target these blood vessels, including bevacizumab (Avastin).
The results from the randomized, double -blind, placebo -controlled, Phase II EPOC (Endothelin A Proof Of Concept) Study of ZD4054 - a specific endothelin A (ETA) receptor antagonist – were delivered at the 14th European Congress of Clinical Oncology (ECCO, 23-27 September, Barcelona).
› Verified 2 days ago